300381 溢多利
已收盘 07-15 15:00:00
资讯
新帖
简况
溢多利：溢倍佳COM系列是公司的洗涤用复合酶
证券之星 · 11:38
溢多利：溢倍佳COM系列是公司的洗涤用复合酶
股市必读：7月3日溢多利发生1笔大宗交易 成交金额802.2万元
证券之星 · 07-06
股市必读：7月3日溢多利发生1笔大宗交易 成交金额802.2万元
7月1日溢多利现813.66万元大宗交易
证券之星 · 07-01
7月1日溢多利现813.66万元大宗交易
溢多利：公司产品和技术目前已应用在营养与健康、护理与清洁、食品与饮料、纸浆与造纸、纺织与皮革、生物能源等领域
证券之星 · 07-01
溢多利：公司产品和技术目前已应用在营养与健康、护理与清洁、食品与饮料、纸浆与造纸、纺织与皮革、生物能源等领域
溢多利：电镀过氧化氢酶产品已于2025年实现销售
证券之星 · 07-01
溢多利：电镀过氧化氢酶产品已于2025年实现销售
溢多利：珠海金湾基地已于2024年底投产
证券之星 · 06-24
溢多利：珠海金湾基地已于2024年底投产
溢多利：公司将结合业务开展情况进一步探讨更为合适的行业分类
证券之星 · 06-24
溢多利：公司将结合业务开展情况进一步探讨更为合适的行业分类
溢多利：基于成本和市场价值综合考量，公司目前暂缓5-ALA产品的规模化量产
证券之星 · 06-17
溢多利：基于成本和市场价值综合考量，公司目前暂缓5-ALA产品的规模化量产
股市必读：溢多利（300381）6月16日董秘有最新回复
证券之星 · 06-17
股市必读：溢多利（300381）6月16日董秘有最新回复
溢多利：销售产品包括饲料用酶及各类工业用酶、植物提取物等
证券之星 · 06-16
溢多利：销售产品包括饲料用酶及各类工业用酶、植物提取物等
溢多利公布国际专利申请：“一种葡萄糖氧化酶突变体及其制备方法与应用”
证券之星 · 06-06
溢多利公布国际专利申请：“一种葡萄糖氧化酶突变体及其制备方法与应用”
【机构调研记录】天治基金调研溢多利
证券之星 · 05-18
【机构调研记录】天治基金调研溢多利
溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%
证券之星 · 05-13
溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%
溢多利(300381)4月30日股东户数2万户，较上期减少0.92%
证券之星 · 05-11
溢多利(300381)4月30日股东户数2万户，较上期减少0.92%
股市必读：溢多利（300381）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：溢多利（300381）5月8日披露最新机构调研信息
每周股票复盘：溢多利（300381）Q1净利增238.47%
证券之星 · 05-03
每周股票复盘：溢多利（300381）Q1净利增238.47%
溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-30
溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
图解溢多利一季报：第一季度单季净利润同比增长238.47%
证券之星 · 04-28
图解溢多利一季报：第一季度单季净利润同比增长238.47%
溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%
智通财经 · 04-28
溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
证券之星 · 04-25
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
加载更多
公司概况
公司名称：
广东溢多利生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2014-01-28
主营业务：
广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。
发行价格：
27.88
{"stockData":{"symbol":"300381","market":"SZ","secType":"STK","nameCN":"溢多利","latestPrice":6.02,"timestamp":1784098995000,"preClose":5.96,"halted":0,"volume":9842500,"delay":0,"changeRate":0.0101,"floatShares":478000000,"shares":480000000,"eps":-0.0171,"marketStatus":"已收盘","change":0.06,"latestTime":"07-15 15:00:00","open":5.93,"high":6.11,"low":5.92,"amount":59317900,"amplitude":0.0319,"askPrice":6.03,"askSize":53,"bidPrice":6.02,"bidSize":282,"shortable":0,"etf":0,"ttmEps":-0.0171,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784165400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.96,"symbolType":"stock","openAndCloseTimeList":[[1784079000000,1784086200000],[1784091600000,1784098800000]],"highLimit":6.56,"lowLimit":5.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":480173861,"isCdr":false,"pbRate":1.12,"roa":"--","roe":"0.64%","epsLYR":-0.0403,"committee":-0.178875,"marketValue":2891000000,"turnoverRate":0.0206,"status":0,"floatMarketCap":2880000000},"requestUrl":"/m/hq/s/300381","defaultTab":"news","newsList":[{"id":"2651436579","title":"溢多利：溢倍佳COM系列是公司的洗涤用复合酶","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651436579?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:38","pubTimestamp":1784086704,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)07月15日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，溢倍佳com系列洗涤酶，是属于高端工业酶吗？哪些产品性能已媲美或超过诺维信及杜邦溢多利回复：尊敬的投资者您好，溢倍佳COM系列是公司的洗涤用复合酶，可应用于液体洗涤剂和洗衣粉等产品。目前，公司已形成二元、三元及四元复合酶产品体系，属于洗涤领域技术含量和应用价值较高的工业酶产品。公司将持续加强技术创新，推进高端洗涤复合酶研发，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500019288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","BK0239","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649619979","title":"股市必读：7月3日溢多利发生1笔大宗交易 成交金额802.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649619979","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649619979?lang=zh_cn&edition=full","pubTime":"2026-07-06 04:12","pubTimestamp":1783282334,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，溢多利报收于5.93元，上涨1.72%，换手率1.71%，成交量8.18万手，成交额4809.95万元。交易信息汇总资金流向7月3日主力资金净流出138.91万元，占总成交额0.0%；游资资金净流入129.87万元，占总成交额0.0%；散户资金净流入9.04万元。大宗交易7月3日溢多利发生1笔大宗交易，成交金额802.2万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600001460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0070","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648190535","title":"7月1日溢多利现813.66万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2648190535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648190535?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:38","pubTimestamp":1782898710,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日溢多利发生大宗交易，交易数据如下：大宗交易成交价格5.73元，相对当日收盘价折价2.05%，成交142万股，成交金额813.66万元，买方营业部为广发证券股份有限公司珠海高新金唐路证券营业部，卖方营业部为中国银河证券股份有限公司珠海吉大路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.42万手，折价成交1笔。截至2026年7月1日收盘，溢多利报收于5.85元，上涨4.09%，换手率2.4%，成交量11.46万手，成交额6614.13万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100033633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648910915","title":"溢多利：公司产品和技术目前已应用在营养与健康、护理与清洁、食品与饮料、纸浆与造纸、纺织与皮革、生物能源等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2648910915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648910915?lang=zh_cn&edition=full","pubTime":"2026-07-01 11:35","pubTimestamp":1782876906,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，酶制剂作为生物制造的芯片地位，溢多利一直坚持酶制剂的研发，国内绝对龙头！在高端工业酶方面有哪些布局，有哪些已经实现了国产替代溢多利回复：尊敬的投资者您好，公司产品和技术目前已应用在营养与健康、护理与清洁、食品与饮料、纸浆与造纸、纺织与皮革、生物能源等领域，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100019837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","159151","300381","BK0077","BK0239","159945"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648591719","title":"溢多利：电镀过氧化氢酶产品已于2025年实现销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2648591719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648591719?lang=zh_cn&edition=full","pubTime":"2026-07-01 11:35","pubTimestamp":1782876906,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，溢多利半导体用洗涤酶，研发及生产进度怎么样，实现小批量生产并向大厂送样了吗溢多利回复：尊敬的投资者您好，公司电镀过氧化氢酶产品已于2025年实现销售，目前在对菌种进行持续改造优化，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100019839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645130548","title":"溢多利：珠海金湾基地已于2024年底投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2645130548","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645130548?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:51","pubTimestamp":1782305516,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，目前贵公司内蒙古及珠海金湾新厂已经正式投产了吗，产能利用率如何，本年管理层扭亏为盈的信心如何，谢谢溢多利回复：尊敬的投资者您好，公司珠海金湾基地已于2024年底投产，目前处于产能爬坡阶段，内蒙古溢多利三期工程正处在项目收尾及设备调试阶段，预计将在今年年底全面投入使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400042058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300381","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645586864","title":"溢多利：公司将结合业务开展情况进一步探讨更为合适的行业分类","url":"https://stock-news.laohu8.com/highlight/detail?id=2645586864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645586864?lang=zh_cn&edition=full","pubTime":"2026-06-24 08:55","pubTimestamp":1782262509,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利06月23日在投资者关系平台上答复投资者关心的问题。毕竟这才是正确的调整，而且目前化学制药偏传统右不被资金关注，希望溢多利管理层解释一下，谢谢。公司将结合业务开展情况进一步探讨更为合适的行业分类，感谢您的关注和建议！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400008263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300381","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644460357","title":"溢多利：基于成本和市场价值综合考量，公司目前暂缓5-ALA产品的规模化量产","url":"https://stock-news.laohu8.com/highlight/detail?id=2644460357","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644460357?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:51","pubTimestamp":1781700706,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！公司5- ALA和生物降解酶R-PET进展情况顺利吗，具体进度如何？公司股价如此之低，贵公司应该考虑回购股份。溢多利回复：尊敬的投资者，您好！基于成本和市场价值综合考量，公司目前暂缓5-ALA产品的规模化量产；R-PET酶正在优化酶的产量，以降低生产成本。关于回购股份的建议，公司将结合实际情况进行考虑，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700039412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0070","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644773760","title":"股市必读：溢多利（300381）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644773760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644773760?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:34","pubTimestamp":1781642051,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，溢多利报收于5.83元，上涨0.34%，换手率1.48%，成交量7.09万手，成交额4110.65万元。董秘最新回复投资者： 公司选择巴西发展业务，主要销售重点是是向该地区销售饲料用酶？为进一步完善海外市场营销网络，提高运营效率及响应速度，公司于一季度在巴西设立子公司，负责拉美地区的销售拓展及技术服务工作。当日关注点交易信息汇总：6月16日主力资金净流入102.09万元，占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300381","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643737220","title":"溢多利：销售产品包括饲料用酶及各类工业用酶、植物提取物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2643737220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643737220?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:36","pubTimestamp":1781598970,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：公司选择巴西发展业务，主要销售重点是是向该地区销售饲料用酶？还是能源、工业用酶？是在当地生产，还是国内生产，出口方式销售？公司基于何种考虑在南美开立分公司？溢多利回复：尊敬的投资者，您好！为进一步完善海外市场营销网络，提高运营效率及响应速度，公司于一季度在巴西设立子公司，负责拉美地区的销售拓展及技术服务工作。销售产品包括饲料用酶及各类工业用酶、植物提取物等，目前采用出口方式。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600028948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0077","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641075128","title":"溢多利公布国际专利申请：“一种葡萄糖氧化酶突变体及其制备方法与应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2641075128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641075128?lang=zh_cn&edition=full","pubTime":"2026-06-06 06:23","pubTimestamp":1780698190,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示溢多利（300381）公布了一项国际专利申请，专利名为“一种葡萄糖氧化酶突变体及其制备方法与应用”，专利申请号为PCT/CN2024/134432，国际公布日为2026年6月4日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来溢多利已公布的国际专利申请2个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.05亿元，同比减3.99%。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600002641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0077","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636624012","title":"【机构调研记录】天治基金调研溢多利","url":"https://stock-news.laohu8.com/highlight/detail?id=2636624012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636624012?lang=zh_cn&edition=full","pubTime":"2026-05-18 08:02","pubTimestamp":1779062531,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月15日披露的机构调研信息，天治基金近期对1家上市公司进行了调研，相关名单如下：1）溢多利 调研纪要：公司2025年研发投入占营收12.61%，优化人工智能指导的酶分子改造平台，未来将进一步使用人工智能赋能研发创新。天治基金成立于2003年，截至目前，资产管理规模83.94亿元，排名144/212；资产管理规模79.66亿元，排名126/212；管理公募基金数24只，排名132/212；旗下公募基金经理5人，排名144/212。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800002696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300381","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635358597","title":"溢多利（300381）披露回购股份注销完成暨股份变动公告，5月13日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635358597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635358597?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:36","pubTimestamp":1778682976,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，溢多利报收于7.49元，较前一交易日上涨0.94%，最新总市值为36.78亿元。近日，广东溢多利生物科技股份有限公司发布《关于回购股份注销完成暨股份变动的公告》。公告显示，本次注销回购股份数量为10,887,600股，占注销前总股本的2.22%。注销完成后，公司总股本由491,061,461股变更为480,173,861股。本次回购股份原计划用于员工持股计划或股权激励，因在36个月内未使用，经董事会及股东大会审议通过，变更用途为注销并减少注册资本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0239","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634404258","title":"溢多利(300381)4月30日股东户数2万户，较上期减少0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404258","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634404258?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:27","pubTimestamp":1778491665,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年4月30日公司股东户数为2.0万户，较3月31日减少186.0户，减幅为0.92%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至4月30日，化学制药行业平均股东户数为3.59万户。从股价来看，2026年3月31日至2026年4月30日，溢多利区间涨幅为5.65%，在此期间股东户数减少186.0户，减幅为0.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100024114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0077","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634242999","title":"股市必读：溢多利（300381）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634242999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634242999?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:08","pubTimestamp":1778443693,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，溢多利报收于7.37元，上涨6.2%，换手率4.78%，成交量23.38万手，成交额1.69亿元。公司已于2022年4月出售生物医药相关资产，2025年无医药中间体、甾体激素业务。国内覆盖25个省市，海外布局60多个国家和地区，拥有全球2300多家长期合作优质客户；持续推进“人才与渠道本土化”战略，积极参与展会与技术交流，设立海外分支机构深化布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","BK0239","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632722626","title":"每周股票复盘：溢多利（300381）Q1净利增238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632722626","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632722626?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:51","pubTimestamp":1777755067,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，溢多利报收于6.92元，较上周的6.19元上涨11.79%。本周，溢多利4月29日盘中最高价报7.13元。本周关注点来自业绩披露要点：溢多利2026年一季度归母净利润同比上升238.47%。股本股东变化股东户数变动截至2026年3月31日，溢多利股东户数为2.02万户，较2月27日减少205.0户，减幅1.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0239","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631520017","title":"溢多利（300381）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631520017?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:42","pubTimestamp":1777502527,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期溢多利发布2026年一季报。截至本报告期末，公司营业总收入2.13亿元，同比上升5.06%，归母净利润1648.54万元，同比上升238.47%。本报告期溢多利盈利能力上升，毛利率同比增幅5.22%，净利率同比增幅227.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630370536","title":"图解溢多利一季报：第一季度单季净利润同比增长238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630370536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630370536?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:23","pubTimestamp":1777371809,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利2026年一季报显示，一季度公司主营收入2.13亿元，同比上升5.06%；归母净利润1648.54万元，同比上升238.47%；扣非净利润1126.41万元，同比上升30.61%；负债率9.27%，投资收益54.42万元，财务费用356.1万元，毛利率49.66%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800054347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630372407","title":"溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630372407","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630372407?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:55","pubTimestamp":1777370110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，溢多利(300381.SZ)发布2026年第一季度报告，该公司营业收入为2.13亿元，同比增长5.06%。归属于上市公司股东的净利润为1648.54万元，同比增长238.47%。归属于上市公司股东的扣除非经常性损益的净利润为1126.41万元，同比增长30.61%。基本每股收益为0.0336元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"溢多利(300381.SZ)发布一季度业绩，归母净利润1648.54万元，增长238.47%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870599","title":"溢多利(300381)3月31日股东户数2.02万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870599?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:12","pubTimestamp":1777108336,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年3月31日公司股东户数为2.02万户，较2月27日减少205.0户，减幅为1.0%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.52万户。从股价来看，2026年2月27日至2026年3月31日，溢多利区间跌幅为6.83%，在此期间股东户数减少205.0户，减幅为1.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0077","300381"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784130733131,"stockEarnings":[{"period":"1week","weight":0.0294},{"period":"1month","weight":0.0347},{"period":"3month","weight":-0.0592},{"period":"6month","weight":-0.146},{"period":"1year","weight":-0.1973},{"period":"ytd","weight":-0.078}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0149},{"period":"6month","weight":-0.0354},{"period":"1year","weight":0.1271},{"period":"ytd","weight":-0.0004}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东溢多利生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20024人(较上一季度减少0.92%)","perCapita":"23893股","listingDate":"2014-01-28","address":"广东省珠海市香洲区南屏高科技工业区屏北一路8号","registeredCapital":"48017万元","survey":" 广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。","listedPrice":27.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"溢多利,300381,溢多利股票,溢多利股票老虎,溢多利股票老虎国际,溢多利行情,溢多利股票行情,溢多利股价,溢多利股市,溢多利股票价格,溢多利股票交易,溢多利股票购买,溢多利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}